Singapore General Hospital will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Help Us Improve Your Experience:

We’d love to hear from you! Rate the SGH website and share your feedback so we can enhance your online experience and serve you better. Click here to rate us

Asst Prof Jolene Wong

MBBS, MMED, FRCS Ed (Gen Surg)

Consultant

Singapore General Hospital Singapore General Hospital

Specialty: General Surgery

Clinical Interests

Colorectal, Gastrointestinal, Gastrointestinal Oncology, General Surgery, Pelvic & Peritoneal, Peritoneal-based Malignancies, Sarcoma, Sarcoma/Skin, Supportive & Palliative Care

Clinical Appointments

Academic Appointments

Clinical Lecturer, NUS YLLSOM

Assistant Professor, Oncology Academic Clinical Programme, SingHealth Duke-NUS Lien Centre for Palliative Care & Signature Research Programme in Health Services & Systems Research

Teaching Faculty: Clinical Teacher, Content Expert, Clinical Practice Facilitator, LKC NTU Medical School

Physician Faculty, SingHealth General Surgery Residency

About Doctor

Dr Jolene Wong is a Consultant at the Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT). She is a fellow of the Royal College of Surgeons (Edinburgh) and holds a Master of Medicine (Surgery). Having completed 2 years of local subspecialty training in the treatment of sarcoma, peritoneal surface malignancy, and skin cancers at the Singapore General Hospital (SGH) and KK Women’s & Children Hospital; Dr Wong continued to pursue her interest in innovative and minimally invasive approaches in the treatment of peritoneal disease at Ghent University Hospital, Belgium where she focused on the conduct of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC).

She also underwent a palliative surgical oncological fellowship at the Brigham and Women Hospital, Boston in 2023. She holds the position of fellow within the Royal College of Surgeons of Edinburgh since 2019. She has been awarded multiple clinical and academic awards in 2025, including the SingHealth Excellence - Distinguished Young Leader Award and the HPHSR Clinician Scientist Award (HCSA).

As a health services researcher with an interest in population health, Dr Wong holds a Master of Public Health (MPH) from the Harvard TH Chan School. A pioneer in palliative surgical care research in Singapore and in the region, Dr Wong revolves her research around improving the quality of life and services encompassing seriously ill palliative patients.

Languages Spoken

  • English
  • Chinese

Education and Training

  • Master of Public Health (MPH), Harvard T.H Chan School of Public Health, USA, May 2023
  • Fellowship of the Royal College of Surgeons (FRCS), Royal College of Surgeons of Edinburgh, Aug 2019
  • Intercollegiate Membership of the Royal College of Surgeons (MRCS), Royal College of Surgeons of Edinburgh, Oct 2018
  • Master of Medicine (Surgery), Royal College of Surgeons of Edinburgh, Jul 2016
  • Bachelor of Medicine & Surgery (MBBS), Yong Loo Lin School of Medicine, NUS, May 2014
  • Graduate Certificate Education Advanced Levels, Raffles Junior College, Jan 2009

Professional Appointments and Committee Memberships

  • Assistant Professor (Research Track), SingHealth Duke-NUS Lien Centre for Palliative Care
  • Deputy Director, SingHealth and Duke-NUS, Health Research Services, Value Driven Care
  • Clinical Lead, Singapore General Hospital, Serious Illness Value-driven Care Workgroup
  • Research Scientist, Centre for Population Health Research and Implementation (CPHRI), SingHealth Regional Health System (RHS)
  • Committee Member, Ministry of Health, End of Life Clinician Workgroup for the Value-driven Care initiative
  • Member, Singapore General Hospital, The Advance Care Planning (ACP) Workgroup in SGH
  • Clinical Assistant Professor, Health Services & Systems Research, Office of Research in Duke-NUS Medical School
  • Clinical Assistant Professor, SingHealth Duke-NUS Surgery and Oncology Academic Clinical Programme (ACP)

Awards

  • SingHealth Excellence Awards – Distinguished Young Leader Award
  • HPHSR Clinician Scientist Award (HCSA)
  • Population Health Research Grant – Open Category
  • PULSES Fellowship Award
  • Population Health Research Grant – New Investigator Grant Award
  • Khoo Scholars Award
  • Singapore General Hospital Research Fellowship Award
  • Nurturing Clinician Scientist Award
  • Dean’s List Excellence Award

Research Trials/Clinical Trials

  • Coaching in surgical ONCology to improve Readiness and Decisions (CONCORD)
  • Effectiveness of A Care Coach-led Integrated Palliative Surgical Oncology and Rehabili-tation Care Model in Patients with Advanced Cancer Undergoing Major Surgery: A Ran-domized Controlled Trial
  • Integrated Prehabilitation and Palliative Care Program in Seriously Ill Older Adults under-going Major Elective Surgery
  • Community-based Surgical Palliative Oncology (SUR-PORT) Care: A novel healthcare de-livery model to optimize end-of-life care in surgical patients
  • Knowledge, Perception, Attitudes with Palliative Care, Carcinomatosis & Surgery
  • Impact of Palliative Surgical Interventions on Advanced Cancer Patients and their Care-givers
  • Phase III Randomized Trial of HIPEC in Primary Stage Three & Four Ovarian Cancer After Interval Cytoreductive Surgery (FOCUS/KOV-HIPEC-04)
  • Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases
  • Pilot Study: Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for colo-rectal cancers at high risk of developing peritoneal metastases.
  • Radical resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treat-ment of high risk recurrent retroperitoneal sarcoma
  • A Phase 3, multicenter, randomized, open-label, parallel group, treatment study to as-sess the efficacy and safety of the lifileucel (LN-144, autologous tumor-infiltrating lym-phocytes [TIL]) regimen in combination with pembrolizumab compared with pembroli-zumab monotherapy in participants with untreated, unresectable or metastatic mela-noma [Protocol Number: IOV-MEL-301]

Publications

  1. Prevalence of Preoperative Palliative Care Needs and Associations with Healthcare Use and Cost Among Older Adults Undergoing Major Elective surgery. Wong JSM, Wang Y, Bollens-Lund E, Reich AJ, Dhanani H, Ankuda CK, Lipsitz S, Gray TF, Ritchie CS, Tabata-Kelly M, Cooper Z. J Am Coll Surg. 2025 Nov 1;241(5):875-886. [Q1; JIF: 6.5]
  2. Long-term Changes in Pain, Depression, Function and Informal Caregiving after Major Elective Surgeries Among Seriously Ill Older Adults. Wong JSM, Wang Y, Bollens-Lund E, Reich AJ, Dhanani H, Ankuda CK, Lipsitz S, Gray TF, Kim DH, Ritchie CS, Kelley AS, Cooper Z. Annals of Surgery. May 2025;281(5):806-813. [Q1; JIF: 6.4]
  3. Prehabilitation Outcomes in Surgical Oncology Patients Undergoing Major Abdominal Surgery: A Meta-analysis of Randomized Control Trials. Soh NH, Yau CRZ, Low XZ, Kadir HA, Fong WJ, Ramalingam MB, Tan PL, NG KYY, Hsing YT, Cai M, Seo CJ, Ong JCA, Chia CS, Wong JSM#. Annals of Surgical Oncology. 2024 Nov 30. [Q1; JIF: 3.5]
  4. Natural Language Processing for Serious Illness Communications in Palliative Surgical Oncology. Wong LCK, Shannon NB, Zhuang Q, Abdullah HR, Fong WJ, Chia CS, Wong JSM#. Annals Academy of Medicine Singapore. 2024 Nov 18; 53(11). [Q3; JIF:8.7]
  5. Implementation of a Multi-Disciplinary Team and Quality of Goals of Care Discussions in Palliative Surgical Oncology Patients. Soon JJY, Juan WKD, Ong WS, Bek S, Neo PSH, Salazar E, Zhuang KD, Tan YP, Chia CS, Wong JSM#. Ann Surg Oncol. 2023 Dec;30(13):p 8109-8110. [Q1; JIF: 3.5]
  6. ASO Author Reflections: Enhancing Palliative Care Delivery: The Potential of Multi-Disciplinary Intervention Teams for Surgical Oncology Patients. Juan WKD, Soon JJY, Wong JSM#. Ann Surg Oncol. 2023 Dec 1. [Q1; JIF:3.5]
  7. Knowledge and thresholds for palliative care and surgery among healthcare providers caring for adults with serious illness. Juan WKD, Ng IAT, Wong LCK, Fong WJ, Lee PP, Lie SA, Zhou JX, Cai M, Ong JC, Seo JCJ, Chia CS, Wong JSM#. Front Med. 2024 May 31;11:1351864. [Q1; JIF: 3.0]
  8. Novel use of natural language precession for registry development in peritoneal surface malignancies. Shannon NB, Wong LCK, Nakayama M, Tran NTA, Cheng LTE, Thing CH, Abdullah HRB, Juan WKD, Lum MJD, Ong CAJ, Seo CJ, Chia CS, Wong JSM#. Info Med Unlocked. 2023 Jul 14; 101309. [Q2; JIF: 2.4]
  9. Trajectories of Patient-Reported Outcomes after Palliative Gastrointestinal Surgery in Advanced Cancer: Is Good Quality of Life Sustainable? Wong JSM, Ng IAT, Juan WKD, Ong WS, Yang GM, Finkelstein EA, Gandhi M, Ong CAJ, Seo CJ, Zhu HY, Chia CS. Annals of Surgery Open. 2022 Dec;3(4):p e206. [Q1; JIF:6.4]
  10. Palliative Gastro-intestinal Surgery in Patients with Advanced Peritoneal Carcinomato-sis: Clinical Experience and Development of a Predictive Model for Surgical Out-comes. Wong JSM, Lek SM, Lim YZD, Chia CS, Tan GHC, Ong C-AJ, Teo MCC. Front On-col. 2022 Jan 13; 11:811743. [Q2; JIF: 3.3]
  11. Development and Implementation of a Surgeon-Tailored Serious Illness and Palliative Care Education Program. Zhong XF, Yee A, Lim YM, Phua G, Sui AL, Chia CS, Tan YG, Tay G, Teo JY, Wong JSM# Journal of Surgical Education 2026 Jan;83(1):103753 [Q1; JIF: 2.6]
  12. Palliative Care Education Programs for Surgeons: A Review of Current Curriculum and Education Outcomes. Hui SXC, Paik B, Soh NH, Yang YF, Y ACP, Sui AL, Tay GCA, Teo JY, Tan YG, Cai MZ, Seo JC, Ong JCA, Chia CS, Wong JSM#. Journal of Surgical Education 2025 Nov;82(11):103690. [Q1; JIF: 2.6]